All Stories

  1. To Explore Potential Inhibitors against Various Enzymatic Targets of Human African Trypanosomiasis
  2. To Explore the Putative Molecular Targets of Diabetic Nephropathy and their Inhibition Utilizing Potential Phytocompounds
  3. Exploring the Biochemical Mechanisms of Fluoroquinolone Compounds against Tuberculosis by Utilizing Molecular Docking and Quantitative Structure-amino Acid Relationship
  4. QSAR of SARS-CoV-2 Main Protease Inhibitors Utilizing Theoretical Molecular Descriptors
  5. Exploring the SARS-Cov-2 Main Protease (Mpro) and RdRp Targets by Updating Current Structure-based Drug Design Utilizing Co-crystals to Combat COVID-19
  6. Repurposing of Drugs and HTS to Combat SARS-CoV-2 Main Protease Utilizing Structure-Based Molecular Docking
  7. Exploring Current Role of Nanotechnology Used in Food Processing Industry to Control Food Additives and their Biochemical Mechanisms
  8. Natural Sourced Traditional Indian and Chinese Medicines to Combat COVID-19
  9. Exploring the Abnormal Signal Transduction Mediated Internet Addiction and Gaming Disorders
  10. Exploring Spike Protein as Potential Target of Novel Coronavirus and to Inhibit the Viability Utilizing Natural Agents
  11. Exploring the COVID-19 Potential Targets: Big Challenges to Quest Specific Treatment
  12. Exploring Targets of Cell Wall Protein Synthesis and Overexpression Mediated Drug Resistance for the Discovery of Potential M. tb Inhibitors
  13. The Antiviral and Antimalarial Drug Repurposing in Quest of Chemotherapeutics to Combat COVID-19 Utilizing Structure-Based Molecular Docking
  14. Phyto-chlorophyllin prevents alloxan-induced toxicity
  15. A Quality by Design Approach of Metronidazole Bigel and Assessment of Antimicrobial Study Utilizing Box-Behnken Design
  16. In Silico Factorial Screening and Optimization of Chitosan Based Gel for Urapidil Loaded Microparticle using Reduced Factorial Design
  17. Current Development on Chitosan-based Antimicrobial Drug Formulations for the Wound Healing
  18. Abnormal Signal Transduction via Over-expression of Pim-1 Regulated Senescence, Cell Cycle, Apoptosis and Metastatic Invasion: Novel Anticancer Targets and Their Potent Inhibitors from Marine Sources
  19. To Explore the Potential Targets and Current Structure-based Design Strategies Utilizing co-crystallized Ligand to Combat HCV
  20. Computer aided chitosan anchor nanoparticles
  21. QSAR and molecular docking studies of lethal factor protease inhibitors against Bacillus anthracis
  22. Identification of Therapeutically Active Molecules against Anthrax through Structure and Ligand based Drug Design
  23. Zika virus. Zika Viral Targets. Synthetic and Natural Sourced Inhibitors.
  24. Signal Transduction through JAK-STAT and NF-κB Regulated Pim-1 Kinase: Novel Target for Anticancer Leads
  25. Recent Trends in Design and Developments of New Drugs for the Treatment of Cancer, Rheumatoid arthritis, and Parkinson’s Disease-Associated to Abnormal Signal Transduction
  26. Current Drug Design Strategies for Fighting Against Swine Influenza
  27. Recent Advances in Ligand and Structure Based Screening of Potent Quorum Sensing Inhibitors Against Antibiotic Resistance Induced Bacterial Virulence
  28. In-silico combinatorial design and pharmacophore modeling of potent antimalarial 4-anilinoquinolines utilizing QSAR and computed descriptors
  29. In silico evaluation of 6-(2,6-dichlorophenyl)-pyrido[2,3-d]pyrimidin-7(8H)-one compounds: an insight into design of less toxic anticancer drugs
  30. QSAR and structure based design of selective GABA-A receptor antagonists
  31. QSAR and Drug Design
  32. QSAR and pharmacophore modeling of indole-based C-3 pyridone compounds as HCV NS5B polymerase inhibitors utilizing computed molecular descriptors
  33. QSAR modeling of 4-anilinofuro[2,3-b]quinolines: an approach to anticancer drug design
  34. Formulation of saquinavir mesylate loaded microparticle by counterion induced aggregation method: Approach by hyperosmotic technique
  35. Formulation and design of sustained release matrix tablets of metformin hydrochloride: Influence of hypromellose and polyacrylate polymers
  36. Quantitative structure-activation barrier relationship modeling for Diels-Alder ligations utilizing quantum chemical structural descriptors
  37. Importance of Kier-Hall Topological Indices in the QSAR of Anticancer Drug Design
  38. Design of fast dissolving amlodipine besylate tablet formulations
  39. Activity Prediction of Some Nontested Anticancer Compounds Using GA-Based PLS Regression Models
  40. In silicodesign of potent EGFR kinase inhibitors using combinatorial libraries
  41. QSAR of aminopyrido[2,3-d]pyrimidin-7-yl derivatives: Anticancer drug design by computed descriptors
  42. 3D-QSAR and molecular docking studies of 4-anilinoquinazoline derivatives: a rational approach to anticancer drug design
  43. Anticancer Activity of Selected Phenolic Compounds: QSAR Studies Using Ridge Regression and Neural Networks
  44. QSAR Analysis of BABQ compounds via calculated molecular descriptors